The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
Stocktwits on MSN
Pfizer CEO eyes big push towards obesity drug development in 2026 after $10B Metsera acquisition
Pfizer scrapped its own obesity drug candidate, Danuglipron, in early 2025, citing risks of liver enzyme elevations. ・The ...
Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...
The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors, and the general public. Researchers have ...
In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...
Hosted on MSN
Why Tablet Hardness Matters in Drug Development
Produced in Partnership with ERWEKAReviewed by Emily MageeJan 6 2025 Tablets are the most common solid dosage form of medication by far, with over one trillion produced annually. 1 Tablets are mainly ...
Dec 11 (Reuters) - AnaptysBio (ANAB.O), opens new tab said on Wednesday it would end the development of its eczema drug after it failed to meet the main and secondary goals of a mid-stage trial. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback